It may be difficult to choose a suitable statin for elderly patients with primary hypercholesterolaemia
or combined dyslipidaemia who are taking other medications, and this study demonstrates that the majority of these patients can achieve and sustain goal with the starting dose of 2 mg of pitavastatin once daily.
4) describe the Cape Town experience of familial hypercholesterolaemia
(FH) (which occurs in about 0.
The unique experience of the Cape Town team with over 1 000 patients with familial hypercholesterolaemia
(FH) is documented comprehensively by Jean Firth and David Marais.
and associated vascular disease are prevalent in the Western world.
Inappropriate attention was given to the hypercholesterolaemia
, and the disproportionate rise in triglyceride concentration was not recognised as the clue to elevated chylomicron concentration.
It can sometimes, although rarely, be caused by a condition that runs in the family called familial hypercholesterolaemia
Pitavastatin Represents Long-Term Treatment Option for Patients With Primary Hypercholesterolaemia
or Combined Dyslipidaemia
5-20 mg for the treatment of hypercholesterolaemia
Around 110,000 people in the UK are thought to have familial hypercholesterolaemia
- a condition where high cholesterol runs in families.
uk/get-involved/national-cholesterol-month Six in 10 adults in the UK have raised cholesterol and at least one in 500 people are born with a high cholesterol condition called Familial Hypercholesterolaemia
The European commission approved marketing authorisation in July for Repatha for adults with primary hypercholesterolaemia
or mixed dyslipidemia, as an adjunct to diet in combination with a statin or with other lipid-lowering therapies in patients unable to reach LDL cholesterol targets taking statins.
Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated to reduce elevated total cholesterol, LDL-C, Apo B, and triglyceride, and increase HDL-C in adults with primary hypercholesterolaemia
and mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.